Security key
03969T109
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT)
CUSIP: 03969T109
Q1 2021 13F Holders as of 31 Mar 2021
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 18,787,112
- Total 13F value
- $775,920,001
- Share change
- -1,100,668
- Put/Call ratio
- 73%
- SEC-reported price per share
- $41.30
- Number of holders
- 153
- Value change
- -$48,861,238
- Number of buys
- 93
- Number of sells
- 63
- Shares outstanding
- 28,423,877
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2021
Institutions
153
Top holders
10
ARCT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2021
Previous quarter: Q4 2020
Arcturus Therapeutics Holdings Inc. SEC filings
Arcturus Therapeutics Holdings Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03969T109
Recent filing periods:
Ownership snapshot
Top reported holders of ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARK Investment Management...
Disclosed value leader
ARK Investment Management...
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F
Lead comparable stake: 14%
Showing 1-6 of 15 holder rows.
Quick read
ARK Investment Management LLC leads the comparable SEC ownership view at 14%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARK Investment Management LLC's linked filing trail.
Comparable ownership
Top 5
ARK Investment Management LLC
14%
FEDERATED HERMES, INC.
12%
BlackRock Finance, Inc.
6.3%
PRICE T ROWE ASSOCIATES INC /MD/
5%
ORBIMED ADVISORS LLC
4.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARK Investment Management LLC |
13F
Company
|
14%
|
$171,742,000
3,959,019 shares
|
— | 31 Dec 2020 |
| FEDERATED HERMES, INC. |
13F
Company
|
12%
|
$149,783,000
3,452,810 shares
|
— | 31 Dec 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
6.3%
|
$77,301,000
1,781,955 shares
|
— | 31 Dec 2020 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
5%
|
$61,694,000
1,422,179 shares
|
— | 31 Dec 2020 |
| ORBIMED ADVISORS LLC |
13F
Company
|
4.5%
|
$55,530,000
1,280,086 shares
|
— | 31 Dec 2020 |
| VANGUARD GROUP INC |
13F
Company
|
4.2%
|
$51,292,000
1,182,382 shares
|
— | 31 Dec 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
153
Shares
18,787,112
Rows available
153
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
131
Q1 2021 holders
153
Holder diff
22
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 value | Q1 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend